Stay updated on SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Sign up to get notified when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.

Latest updates to the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAn NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” across NIH content. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the previous study record content and attached documents; users cannot view the study details.SummaryDifference20%

- Check43 days agoChange DetectedThe page's revision tag was updated from v3.6.6 to v3.7.0. This reflects an administrative update to the study record's version history rather than a change to study details or content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating an internal update to the study page. The change does not alter the study details visible to users.SummaryDifference0.0%

- Check64 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added to the study identifiers, indicating NIH funding information associated with the trial.SummaryDifference0.0%

Stay in the know with updates to SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SY-1425 Biomarker-Directed Trial in AML/MDS Clinical Trial page.